279 related articles for article (PubMed ID: 10960940)
1. Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
Scagliotti GV
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):15-9. PubMed ID: 10960940
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer.
Scagliotti GV; Novello S
Lung Cancer; 2002 Nov; 38 Suppl 2():S13-9. PubMed ID: 12431824
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
[TBL] [Abstract][Full Text] [Related]
4. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer.
Rinaldi M; Crinò L
Lung Cancer; 2001 Dec; 34 Suppl 4():S25-30. PubMed ID: 11742699
[TBL] [Abstract][Full Text] [Related]
6. [Gemcitabine and cisplatin as induction therapy for patients with histologically proven stage IIIA-N2 non-small-cell bronchial cancer: a phase-II study of the EORTC Cooperative Group (EORTC 08955)].
Malayeri R; Huber H
Strahlenther Onkol; 2001 Apr; 177(4):223-4. PubMed ID: 11370560
[No Abstract] [Full Text] [Related]
7. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.
Garrido P; González-Larriba JL; Insa A; Provencio M; Torres A; Isla D; Sanchez JM; Cardenal F; Domine M; Barcelo JR; Tarrazona V; Varela A; Aguilo R; Astudillo J; Muguruza I; Artal A; Hernando-Trancho F; Massuti B; Sanchez-Ronco M; Rosell R
J Clin Oncol; 2007 Oct; 25(30):4736-42. PubMed ID: 17947721
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
Cappuzzo F; Selvaggi G; Gregorc V; Mazzoni F; Betti M; Rita Migliorino M; Novello S; Maestri A; De Marinis F; Darwish S; De Angelis V; Nelli F; Bartolini S; Scagliotti GV; Tonato M; Crinò L
Cancer; 2003 Jul; 98(1):128-34. PubMed ID: 12833465
[TBL] [Abstract][Full Text] [Related]
10. Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2
Zhong WZ; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang X; Yan W; Yan HH; Liao RQ; Yang JJ; Zhang XC; Zhou Q; Wu YL
J Clin Oncol; 2019 Sep; 37(25):2235-2245. PubMed ID: 31194613
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G;
Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study.
De Pas T; Curigliano G; Veronesi G; Catalano G; Catania C; Jereczek-Fossa B; Orecchia R; Spaggiari L; de Braud F
Bull Cancer; 2004 Sep; 91(9):E273-7. PubMed ID: 15582897
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Detterbeck FC; Socinski MA; Gralla RJ; Edelman MJ; Jahan TM; Loesch DM; Limentani SA; Govindan R; Zaman MB; Ye Z; Monberg MJ; Obasaju CK
J Thorac Oncol; 2008 Jan; 3(1):37-45. PubMed ID: 18166839
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer.
De Marinis F; Gebbia V; De Petris L
Ann Oncol; 2005 May; 16 Suppl 4():iv116-122. PubMed ID: 15923411
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of gemcitabine in combination with cisplatin in a randomized study of untreated patients with advanced non-small-cell lung carcinoma].
Mehić B; Zutić H; Dizdarević Z; Lomigorić J
Med Arh; 2004; 58(1):11-3. PubMed ID: 15017896
[TBL] [Abstract][Full Text] [Related]
17. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis.
Ma D; Wang J; Hao X; Wang Y; Hu X; Xing P; Li J
Thorac Cancer; 2017 Sep; 8(5):482-488. PubMed ID: 28745824
[TBL] [Abstract][Full Text] [Related]
19. Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.
Huisman C; Giaccone G; van Groeningen CJ; Sutedja G; Postmus PE; Smit EF
Lung Cancer; 2001; 33(2-3):267-75. PubMed ID: 11551422
[TBL] [Abstract][Full Text] [Related]
20. A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
Kontopodis E; Kotsakis A; Kentepozidis N; Syrigos K; Ziras N; Moutsos M; Filippa G; Mala A; Vamvakas L; Mavroudis D; Georgoulias V; Agelaki S
Cancer Chemother Pharmacol; 2016 May; 77(5):949-56. PubMed ID: 26994909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
